Minerva Neurosciences Management
Management criteria checks 2/4
Minerva Neurosciences' CEO is Remy Luthringer, appointed in Nov 2014, has a tenure of 9.5 years. total yearly compensation is $1.84M, comprised of 34% salary and 66% bonuses, including company stock and options. directly owns 2.64% of the company’s shares, worth €408.81K. The average tenure of the management team and the board of directors is 8.1 years and 8.8 years respectively.
Key information
Remy Luthringer
Chief executive officer
US$1.8m
Total compensation
CEO salary percentage | 34.0% |
CEO tenure | 9.5yrs |
CEO ownership | 2.6% |
Management average tenure | 8.1yrs |
Board average tenure | 8.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | US$2m | US$624k | -US$30m |
Sep 30 2023 | n/a | n/a | -US$28m |
Jun 30 2023 | n/a | n/a | -US$27m |
Mar 31 2023 | n/a | n/a | -US$29m |
Dec 31 2022 | US$1m | US$600k | -US$32m |
Sep 30 2022 | n/a | n/a | -US$47m |
Jun 30 2022 | n/a | n/a | -US$49m |
Mar 31 2022 | n/a | n/a | -US$51m |
Dec 31 2021 | US$1m | US$585k | -US$50m |
Sep 30 2021 | n/a | n/a | -US$36m |
Jun 30 2021 | n/a | n/a | -US$35m |
Mar 31 2021 | n/a | n/a | US$5m |
Dec 31 2020 | US$2m | US$565k | US$2m |
Sep 30 2020 | n/a | n/a | -US$21m |
Jun 30 2020 | n/a | n/a | -US$27m |
Mar 31 2020 | n/a | n/a | -US$69m |
Dec 31 2019 | US$1m | US$543k | -US$72m |
Sep 30 2019 | n/a | n/a | -US$55m |
Jun 30 2019 | n/a | n/a | -US$54m |
Mar 31 2019 | n/a | n/a | -US$54m |
Dec 31 2018 | US$4m | US$525k | -US$50m |
Sep 30 2018 | n/a | n/a | -US$37m |
Jun 30 2018 | n/a | n/a | -US$36m |
Mar 31 2018 | n/a | n/a | -US$33m |
Dec 31 2017 | US$2m | US$445k | -US$32m |
Compensation vs Market: Remy's total compensation ($USD1.84M) is above average for companies of similar size in the German market ($USD400.67K).
Compensation vs Earnings: Remy's compensation has increased whilst the company is unprofitable.
CEO
Remy Luthringer (62 yo)
9.5yrs
Tenure
US$1,835,160
Compensation
Dr. Remy Luthringer, Ph D., serves as a Clinical Advisor to the Medicxi investment team and a Member of the Co-Founding team at Medicxi Ventures (UK) LLP. He has played an active role in several Index Vent...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive Chairman & CEO | 9.5yrs | US$1.84m | 2.64% $ 408.8k | |
President | 2.6yrs | US$1.40m | 0.73% $ 113.5k | |
Senior VP | 2.6yrs | US$965.12k | 0.25% $ 38.7k | |
Senior VP & COO | 9.8yrs | US$1.49m | no data | |
Vice President of Investor Relations & Corporate Communications | 8.8yrs | no data | no data | |
Chief Medical Officer | 7.4yrs | US$657.47k | no data |
8.1yrs
Average Tenure
62yo
Average Age
Experienced Management: 4MNA's management team is seasoned and experienced (8.1 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive Chairman & CEO | 9.5yrs | US$1.84m | 2.64% $ 408.8k | |
Independent Director | 5.8yrs | US$128.25k | 0.0018% $ 276.9 | |
Independent Director | 9.8yrs | US$120.75k | 0.036% $ 5.6k | |
Independent Director | 6.4yrs | US$127.00k | 0.018% $ 2.8k | |
Lead Independent Director | 8.5yrs | US$125.25k | 0.34% $ 52.9k | |
Independent Director | 9yrs | US$122.25k | 0% $ 0 |
8.8yrs
Average Tenure
66.5yo
Average Age
Experienced Board: 4MNA's board of directors are considered experienced (8.8 years average tenure).